Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Right now, patients with obesity and cirrhosis ...
Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...
News Medical on MSN
Unraveling liver injury mechanisms in familial hypobetalipoproteinemia
Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal ...
New data links the liver receptor GPR110 to sex-specific progression of metabolic dysfunction-associated steatohepatitis.
Newly discovered mechanism by which oral bacteria affect gut health coincides with worsening liver health in patients with ...
New analysis shows alcohol-related liver disease remains a major cause of cirrhosis and liver death. Read more.
The FDA expanded the indication for semaglutide (Wegovy) to treating adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), the agency announced. The glucagon-like peptide-1 ...
Cholesterol buildup in liver fat droplets directly drives fibrosis in metabolic disease, study finds
Cholesterol plays a vital role in the body, providing structural support to cells and serving as a building block for hormone synthesis. However, when cholesterol accumulates or is improperly ...
The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results